CNBC February 13, 2024
Key Points
– A federal judge dismissed a lawsuit brought by a major pharmaceutical industry lobbying group and two other organizations challenging Medicare drug price negotiations.
– The decision is an early win for the Biden administration as it grapples with a flurry of other legal challenges from drugmakers to the Inflation Reduction Act’s price talks.
– U.S. Judge David Ezra of the Western District of Texas sided with the Biden administration in dismissing the suit by PhRMA, the Global Colon Cancer Association and the National Infusion Center Association.
A federal judge on Monday dismissed a lawsuit brought by a major pharmaceutical industry lobbying group and two other organizations that challenged Medicare’s new powers to negotiate prices for costly prescription...
Today's Sponsors
Today's Sponsor